AAAAAA
Results: 476-500/1363
Authors:
Loiseau, P
Loiseau, J
Citation: P. Loiseau et J. Loiseau, Epilepsy or epilepsies?, REV NEUROL, 155(3), 1999, pp. 193-198
Authors:
Durieux, A
Flocard, F
Ferreira, A
Azulay, JP
Felten, O
Navarro, V
Chedru, F
Pouget, J
Bequet, D
Clavelou, P
Citation: A. Durieux et al., Superficial siderosis of the central nervous system., REV NEUROL, 155(3), 1999, pp. 201-207
Authors:
Besson, G
Vincent, E
Hommel, M
Perret, J
Citation: G. Besson et al., Ataxic hemiparesia due to lacunar infarct., REV NEUROL, 155(3), 1999, pp. 209-212
Authors:
Gouider, R
Samet, S
Triki, C
Fredj, M
Gargouri, A
El Bahri, F
Ben Ghorbel, I
Kasraoui, A
Mhiri, C
Mrabet, A
Citation: R. Gouider et al., Neurological manifestations revealing brucellosis., REV NEUROL, 155(3), 1999, pp. 215-218
Authors:
Champel, V
Radal, M
Moulin-Vallez, M
Jonville-Bera, AP
Autret-Leca, E
Citation: V. Champel et al., Should folic acid be given to women treated with valproic acid and/or carbamazepine?, REV NEUROL, 155(3), 1999, pp. 220-224
Authors:
Lettry-Trouillat, R
Kuntzer, T
Janzer, RC
Bogousslavsky, J
Citation: R. Lettry-trouillat et al., Facial myositis: a localized form of generalized myositis?, REV NEUROL, 155(3), 1999, pp. 225-228
Authors:
Rolland, Y
Mazieres, B
Laroche, M
Citation: Y. Rolland et al., Steinert disease and Klinefelter syndrome association., REV NEUROL, 155(3), 1999, pp. 229-230
Authors:
Hadi, M
Boncoeur-Martel, MP
Bouteille, B
Preux, PM
Bernet-Bernardy, P
Dumas, M
Vallat, JM
Couratier, P
Citation: M. Hadi et al., Histoplasma capsulatum histoplasmosis in an HIV-negative patient., REV NEUROL, 155(3), 1999, pp. 231-233
Authors:
Verret, JM
Citation: Jm. Verret, Transcutaneous neurostimulation, REV NEUROL, 155(3), 1999, pp. 234-236
Citation: French Society of Neuropathology - December 4 & 5, 1998, Paris - Abstracts, REV NEUROL, 155(3), 1999, pp. 237-243
Authors:
Sindou, P
Anani, T
Garbay, B
Couratier, P
Lagrange, E
Vallat, JM
Citation: P. Sindou et al., Involvement of myelin proteins in hereditary neuropathies., REV NEUROL, 155(2), 1999, pp. 97-110
Authors:
Arvanitakis, Z
Tounsi, H
Pillon, B
Dubois, B
Citation: Z. Arvanitakis et al., Frontotemporal dementia: clinical approach., REV NEUROL, 155(2), 1999, pp. 113-119
Authors:
Genton, P
Citation: P. Genton, Limitations of the idiopathic generalized epilepsies classification., REV NEUROL, 155(2), 1999, pp. 121-128
Authors:
Crespel, A
Coubes, P
Baldy-Moulinier, M
Citation: A. Crespel et al., Effect of awakening and sleep deprivation in triggering idiopathic generalized seizures., REV NEUROL, 155(2), 1999, pp. 131-134
Authors:
van Thanh, L
Loc, LT
Hung, NT
Hoan, NH
Xuan, DT
van Thanh, N
Buu, PM
Citation: L. Van Thanh et al., Strokes in southern Vietnam: an epidemiology survey., REV NEUROL, 155(2), 1999, pp. 137-140
Authors:
Vercelletto, M
Delchoque, C
Magne, C
Huvet, M
Lanier, S
Feve, JR
Citation: M. Vercelletto et al., Analysis of neuropsychological disorders coupled with 99m Tc-HMPAO SPECT in amyotrophic lateral sclerosis., REV NEUROL, 155(2), 1999, pp. 141-147
Authors:
Brandel, JP
Beaudry, P
Delasnerie-Laupretre, N
Laplanche, JL
Citation: Jp. Brandel et al., Creutzfeldt Jakob disease: diagnostic value of protein 14-3-3 and neuronalspecific enolase assay in cerebrospinal fluid., REV NEUROL, 155(2), 1999, pp. 148-151
Authors:
Milhaud, D
Bernardin, G
Roger, PM
Magnie, M
Mattei, M
Citation: D. Milhaud et al., Central apnea with consciousness impairment due to Listeria rhombencephalitis sequelae., REV NEUROL, 155(2), 1999, pp. 152-154
Authors:
Mackowiak, A
Stojkovic, T
Hurtevent, JF
Maurage, CA
Vermersch, P
Citation: A. Mackowiak et al., Late onset of type I familiar amyloid polyneuropathy preceded by cardiac manifestations., REV NEUROL, 155(2), 1999, pp. 155-157
Authors:
Mas, JL
Vignes, S
Weschler, B
Laforet, P
Citation: Jl. Mas et al., Headaches, vomiting and left homonymous lateral hemianopia in a 25 year-old man., REV NEUROL, 155(2), 1999, pp. 158-164
Authors:
Fontaine, B
Citation: B. Fontaine, Recently acquired knowledge and advances in the treatment of multiple sclerosis - Biogen Symposium ENS Nice, June 1998 - Foreword, REV NEUROL, 155, 1999, pp. S5-S5
Authors:
Waubant, E
Goodkin, D
Citation: E. Waubant et D. Goodkin, How should phase III therapeutic trials in multiple sclerosis be evaluated: advances and challenges, REV NEUROL, 155, 1999, pp. S7-S12
Authors:
Vermersch, P
Citation: P. Vermersch, Interferon beta-1 (Avonex (TM)): clinical and MRI impacts., REV NEUROL, 155, 1999, pp. S13-S19
Authors:
Waubant, E
Sloan, R
Andersson, PB
Goodkin, D
Citation: E. Waubant et al., A pilot study of the effect of weekly intramuscular 30 mcg interferon beta-1a (Avonex (TM)) on monthly gadolinium-enhanced brain MRI activity in patients with relapsing multiple sclerosis., REV NEUROL, 155, 1999, pp. S20-S23
Authors:
Allain, H
Bentue-Ferrer, D
Schuck, S
Ruffault, A
Citation: H. Allain et al., beta interferons in multiple sclerosis: pharmacological differences., REV NEUROL, 155, 1999, pp. S24-S30